Elicio Therapeutics Files 8-K
Ticker: ELTX · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1601485
| Field | Detail |
|---|---|
| Company | Elicio Therapeutics, Inc. (ELTX) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: other-events, filing-update
Related Tickers: ELIO
TL;DR
Elicio Therapeutics (ELIO) filed an 8-K for 'Other Events' on Aug 5. Details TBD.
AI Summary
Elicio Therapeutics, Inc. filed an 8-K on August 5, 2025, reporting an "Other Events" item. The company, formerly known as Angion Biomedica Corp. until February 28, 2014, is incorporated in Delaware and headquartered in Boston, MA. The filing does not disclose specific details about the 'Other Events' but confirms the report date and the company's status.
Why It Matters
This filing indicates a material event has occurred for Elicio Therapeutics, requiring public disclosure. Investors should monitor for further information regarding the nature of these 'Other Events'.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events', which can cover a wide range of material information, necessitating further investigation into the specific event.
Key Numbers
- 001-39990 — SEC File Number (Identifies the company's filing with the SEC.)
- 11-3430072 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Elicio Therapeutics, Inc. (company) — Registrant
- Angion Biomedica Corp. (company) — Former company name
- August 5, 2025 (date) — Report date
- February 28, 2014 (date) — Date of name change
- Boston, Massachusetts (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What specific 'Other Events' are being reported by Elicio Therapeutics in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events'.
When was Elicio Therapeutics, Inc. formerly known as Angion Biomedica Corp.?
Elicio Therapeutics, Inc. was formerly known as Angion Biomedica Corp. until February 28, 2014.
What is the principal executive office address for Elicio Therapeutics, Inc.?
The principal executive offices are located at 451 D Street, 5th Floor, Boston, Massachusetts 02210.
What is the SEC file number for Elicio Therapeutics, Inc.?
The SEC file number for Elicio Therapeutics, Inc. is 001-39990.
On what date was this 8-K filing reported?
This 8-K filing was reported on August 5, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Elicio Therapeutics, Inc. (ELTX).